Document is current

Any future updates will be listed below

Lipid profile and safety of rosuvastatin monotherapy versus rosuvastatin plus ezetimibe in high risk coronary artery disease: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s43044-025-00654-y

Published Online: 2025-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark